AMPH
Amphastar Pharmaceuticals, Inc.#38 · 2023EPAYearly return
+119%
Peak return
+140%
Max drawdown
-35%
ADR (20 days)
+4.0%
Base
23 days / -10.2%
Prior run
+24%
Breakout volume
3.9x
Pivot
$33.13
Catalyst Earnings/Guidance2023-03-01Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Beat EstimatesZacks Investment Research
Earnings, Guidance oder Umsatz-/EPS-Revision als Neubewertungsanker.
Healthcare · Healthcare & Biotech
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare AMPH with the current market directly.